S.Erdine(Turkey), C.Erdöl(Turkey), R.Kreutz(Germany), E.Lurbe(Spain), G.Mancia(Italy)
|10.30- 12.00||Session 1
Chairpersons: Y.Karakoc (Turkey),E.Lurbe (Spain),G.Mancia (Italy)
|10.30-10.50||Pediatric primary hypertension:Gaps in knowledge and needed research
ABPM in Pediatric Hypertension -Circadian BP Rhythm
E.Wühl ( Germany)
Carotid Intima-Media Thickness in adolescence and young adulthood: The association With Obesity and Hypertensive Blood Pressure.
Julia Büschges ( Germany)
|11.30-11.50|| Precision Medicine
A Dominiczak (UK)
Chairperson: S.Erdine (Turkey)
|14.00-14.20||Current evidence for safety and efficacy of renal denervation
V. Aytekin (Turkey)
|14.20-14.40||A glimpse into the ESH position paper on renal denervation
K. Tsioufis (Greece)
|14.40 -15.00||Current technology and technical tips for a successful RDN procedure
A.B. Çatakoğlu (Turkey)
|15.00-15.20||Renal denervation cost-effectiveness analysis
G. Koçkaya (Turkey)
|15.20-15.40||Panel discussion and take home messages|
Chairpersons: S. Erdine (Turkey) , D. Drozdz (Poland)
|16:30-16:40||What is HyperChildNET?: On-going actions to face the challenges
|16:40-16:50||HyperChildNET tools for improving the diagnosis and control of HTN
E.Wühl ( Germany)
|16:50-17:00||Personal experience in HyperChildNET Virtual Mobilities and STSM
K. Azukaitis (Lithuania), J. Álvarez (Spain)
|17:00-17:10||Scientific outputs in HyperChildNET
F.Fernandez Aranda (Spain)
|17:10-17:20||Dissemination. Website. European HyperChildNET week 2022. European Academy of Pediatrics statement.
A. Mazur (Poland)
Chairpersons: E.Wühl(Germany), K. Azukaitis (Lithuania)
|9.30-9.40||BP Measurement in Children and Adolescents
|9.40-9.50||Salt, children and blood pressure
G. Simonetti (Switzerland)
Effect of rational use of medicine
A. Jankauskiene (Lithuania)
|10.00-10.10||Primary hypertension is immunometabolic disease
M. Litwin (Poland)
|10.10-10.30||What can we learn about cardiovascular health from longitudinal surveys on health in children and adolescents? The KIGGS Experience.
H. Neuhauser (Germany)
|10.40 -11.00||Coffee Break|
Chairpersons: S. Stabouli(Greece),A. Jankauskiene.
|11.00-11.15||Eating disorders and Obesity: Shared and differential factors.
|11.15-11.30||Hypertension and Cardiometabolic Syndrome.
M. Sinha (UnitedKingdom)
|11.30-11.45||ObesityandCardio-metabolic Risk Factors:From Childhood to Adulthood.
D. Drozdz (Poland)
|11.45-12.00||Gaming and online gambling in adolescents: A risk combination?
|12.00-12.15||Obesity and Hypertension: The role of selected brain signaling pathways.
|12.15-12.30||Cardiometabolic Syndrome From Microcirculation to Macrocirculation.
S. Sokolovic(Bosnia and Herzegovina)
(Simultaneously, a parallel session will be held for a Management Committee meeting among the MC members of HyperChildNET)
Chairpersons: B.Gorenek(Turkey),D.Lovic (Serbia)
|14.30-15.00||Cardiovascular Risk Assessment:Impact of Psychosocial Factors
|15.00-15.30||Lifestyle therapy in Hypertension :SCHEHERAZADE Study
|15.30-16.00|| Arterial Stiffness
|16.00-16.30||Current and novel antihypertensive medications for resistant hypertension
Chairpersons: Julio Álvarez (Spain), C. Soydaş(Turkey)
|17.00-17.30||COVID-19 in Children
|17.30-18.00||Impact of COVID-19 on Cardiovascular System
|18.00-18.30||Impact of the Post-COVID in Health
Chairpersons: H.Tezcan (Turkey), Ö. F. Beşer (Turkey)
|9.00-9.30||Sympathetic Activation and End Organ Damage in Hypertension
G. Grassi (Italy)
T. Ecder (Turkey)
The challenge of blood pressure goals in diabetes
Chairperson: S.Aytekin(Turkey), Sabahat Ecder(Turkey)
|11.00-11.30||Protection by antihypertensive treatment
G. Mancia (Italy)
|11.30-12.00||Beta blockers in Uncomplicated Hypertension
|12.00-12.30||Hypertension and Atrial Fibrillation-Update
Azerbaijan Society of Cardiology –Turkish Society of Hypertension and Atherosclerosis Joint Session
Chairpersons: T. Ecder(Turkey), S. Erdine (Turkey), U. Rahimov (Azerbaijan)
|14.00-14.20||Treatment of hypertension in CKD: which combination is the best?
|14.20-14.40||Should we use ACE inhibitors in stage 5 CKD?
|14.40-15.00||Important features of treatment in hemodialysis patients
|15.00-15.20||Treatment of patients following kidney transplantation
Chairpersons: J. Redon (Spain), C. Borghi (Italy)
|15.50-16.10||Cuffless Blood Pressure Measuring Devices: new developments
|16.10-16.40||Uric Acid and risk of CVD: recent evidence and implications
C. Borghi (Italy)
|16.40-17.00||Meta-analyses in hypertension research
M. Brunstrom (Sweden)
|17.00-17.20||Novel approaches in hypertension management : E-Health Solutions and Artificial Intelligence
E. Lurbe (Spain), S. Erdine (Turkey), G. Mancia (Italy)
for the Congress
Click on the link below to watch our meeting live.